BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6229439)

  • 1. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloxan-induced free radical production in isolated cells. Selective effect on islet cells.
    Asayama K; Nyfeler F; English D; Pilkis SJ; Burr IM
    Diabetes; 1984 Oct; 33(10):1008-11. PubMed ID: 6383903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.
    Fischer LJ; Hamburger SA
    Diabetes; 1980 Mar; 29(3):213-6. PubMed ID: 6991324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H; Uchigata Y; Okamoto H
    Biochem Biophys Res Commun; 1981 Dec; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
    J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro.
    Jörns A; Tiedge M; Lenzen S; Munday R
    Free Radic Biol Med; 1999 May; 26(9-10):1300-4. PubMed ID: 10381203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T
    Physiol Res; 2001; 50(6):537-46. PubMed ID: 11829314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Diabetes; 1991 Sep; 40(9):1141-5. PubMed ID: 1834504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H; Dahlmann B; Marjanovic SD
    Cell Mol Biol Incl Cyto Enzymol; 1978; 23(4):355-67. PubMed ID: 162617
    [No Abstract]   [Full Text] [Related]  

  • 11. Alloxan-induced luminol luminescence as a tool for investigating mechanisms of radical-mediated diabetogenicity.
    Grankvist K
    Biochem J; 1981 Dec; 200(3):685-90. PubMed ID: 7342976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.
    Wilson GL; Patton NJ; McCord JM; Mullins DW; Mossman BT
    Diabetologia; 1984 Dec; 27(6):587-91. PubMed ID: 6241574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus.
    Welsh N; Margulis B; Borg LA; Wiklund HJ; Saldeen J; Flodström M; Mello MA; Andersson A; Pipeleers DG; Hellerström C
    Mol Med; 1995 Nov; 1(7):806-20. PubMed ID: 8612203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro.
    Sandler S; Swenne I
    Diabetologia; 1983 Nov; 25(5):444-7. PubMed ID: 6228481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired insulin release after exposure of pancreatic islets to autooxidizing dihydroxyfumarate.
    Fischer LJ; Hamburger SA
    Endocrinology; 1981 Jun; 108(6):2331-5. PubMed ID: 7014199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.
    Grankvist K; Marklund S; Sehlin J; Täljedal IB
    Biochem J; 1979 Jul; 182(1):17-25. PubMed ID: 40548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloxan-induced DNA strand breaks in pancreatic islets. Evidence for H2O2 as an intermediate.
    Takasu N; Asawa T; Komiya I; Nagasawa Y; Yamada T
    J Biol Chem; 1991 Feb; 266(4):2112-4. PubMed ID: 1989973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloxan, but not streptozotocin, increases blood perfusion of pancreatic islets in rats.
    Jansson L; Sandler S
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E57-63. PubMed ID: 1386190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.